• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Hims & Hers Partners with Uber to Deliver Personal Care Products

Share:

December 3, 2021

Direct-to-consumer virtual care company Hims & Hers is partnering with Uber to deliver personal care items like skincare, hair products, sleep aids, and condoms to customers via the Uber Eats app.

The service is available now in Los Angeles, San Francisco, Sacramento, Miami, Houston, Austin, Dallas, San Antonio, Philadelphia, Seattle, Atlanta, and Phoenix, although the companies plan to expand to additional cities in the future.

“We have found that adding in the on-demand factor to Hims & Hers products is a game-changer for many consumers,” Hims & Hers COO Melissa Baird said in a statement. “Our relationship with Uber will be the biggest on-demand push we’ve pursued to date, and we are incredibly pleased to offer the ability for so many more people to be able to access our high-quality health and wellness products when they need them.”

WHY IT MATTERS

Launched in 2017, Hims & Hers has been expanding its offerings this year after it went public through a merger with a special purpose acquisition company, a popular method of public exit for digital health startups.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

In September, it launched a dietary supplement geared toward preventing urinary tract infections, and in June, it announced plans to purchase teledermatology platform Apostrophe. Just weeks before that acquisition announcement it snapped up British personalized health company Honest Health, which specializes in hair loss products.

The company is also working with Amazon, Walgreens, and Vitamin Shoppe to sell its health and wellness products.

In its most recent quarterly earnings report, Hims & Hers brought in $74.2 million in revenue compared with $41.3 million in the prior-year period, with a net loss of $15.9 million, compared with $5.9 million from 2020.

THE LARGER TREND

Uber has also been adding to its healthcare-related services. In October, it partnered with senior assistance company Papa in an effort to offer transportation options and decrease social isolation among older adults.

The ride-share and delivery company also partnered with digital prescription platform NimbleRx in 2020 to expand its pharmaceutical delivery offerings.

At the HLTH conference in October, the global head of Uber Health Caitlin Donovan said new ways of providing healthcare services like virtual care and on-demand delivery will increase efficiency and improve the customer experience.

“As we think about providing equitable access to healthcare, you need a lot of components, and virtual care is a huge piece of that,” she said.

“If you can meet people where they are, and then manage by exception, rather than by rules, so you’re only bringing in those folks that really need that clinician’s visit, or meeting them in their home with a prescription delivery [or] a skilled or unskilled caregiver, I think you get a really efficient cost of care, while still meeting people where they are.”

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Baring Private Equity Asia Agrees to Acquire LumenisBaring Private Equity Asia Agrees to Acquire Lumenis
  • Pfizer Completes Acquisition of Array BiopharmaPfizer Completes Acquisition of Array Biopharma
  • Why COVID-19 Highlights Urgent Need to Humanize and Modernize The Patient Financial ExperienceWhy COVID-19 Highlights Urgent Need to Humanize and Modernize The Patient Financial Experience
  • FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot ProgramFCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program
  • Strong Pipeline of Drugs for Treatment Of Psychotic Disorders Anticipated To Drive The Market Through 2028Strong Pipeline of Drugs for Treatment Of Psychotic Disorders Anticipated To Drive The Market Through 2028
  • Complementary and Alternative Medicine Market to Reach $437.9 Billion, Globally, By 2031 at 15.6% CAGR: Allied Market ResearchComplementary and Alternative Medicine Market to Reach $437.9 Billion, Globally, By 2031 at 15.6% CAGR: Allied Market Research
  • YishengBio Raises $130 Million in Series B Funding to Accelerate Pipeline Development and CommercializationYishengBio Raises $130 Million in Series B Funding to Accelerate Pipeline Development and Commercialization
  • Change Healthcare Unveils Breakthrough All-Payer Medical Claim Attachments CapabilityChange Healthcare Unveils Breakthrough All-Payer Medical Claim Attachments Capability

Trending This Week

  • Denials Management Named Most Time-Consuming Task in RCM
  • Why Adopting Value-Based Care Models for Autism Care Is Imperative
  • Why AI-Driven Cancer Screening Will Soon Become Standard of Care
  • Bioventus Completes Divestiture of its Wound Business
  • Enzo Biochem Reports Significant Progress Toward Completing the Clinical Lab Asset Sale
  • eMolecules Acquires Specs Compound Handling B.V.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications